Boehringer Ingelheim has signed a €500m ($572m) agreement with UK-based biotech Tessellate Bio to co-develop targeted cancer therapies for tumours that rely on the alternative lengthening of telomeres ...

Pharmaceutical Technology® Group spoke with Erik Wiklund, CEO of Circio, about the future of M&A in the bio/pharmaceutical industry and the struggle small biotech companies face raising funds.

GlobalData is the parent company of Pharmaceutical Technology. Trade association Biotechnology Innovation Organization (BIO) released survey results and analysis last month, which highlighted that 90% ...

Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, ...

FDA Commissioner Marty Makary last week announced a directive that would limit industry participation in the agency’s ...

Roche's decision to invest heavily in the US – along with Novartis' announcement, has come hard on the heels of European ...

The Bio Pharmaceuticals Market is a rapidly evolving sector within the healthcare industry, characterized by the development of drugs derived from biological sources. This market has gained ...

President Donald J. Trump’s imposition of steep “reciprocal tariffs,”—which he later paused for 90 days—to help bring ...

The Commerce Department has begun a so-called Section 232 investigation into the national security effects of the U.S.